Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease,☆☆,,★★

https://doi.org/10.1016/S0091-6749(96)70103-3Get rights and content
Under a Creative Commons license
open archive

Abstract

BACKGROUND: Chronic allergic conjunctivitis comprises a spectrum of diseases including atopic keratoconjunctivitis, atopic blepharoconjunctivitis, vernal keratoconjunctivitis, and contact lens–associated giant papillary conjunctivitis. Each condition is characterized by a complex immunopathology with a mixed cellular infiltrate. Treatment with conventional mast cell stabilizers is often unsatisfactory, and therapy depends heavily on topical corticosteroids. OBJECTIVE: Recent evidence suggests that T lymphocytes play an important role in mediating the immunopathology seen in the chronic allergic response in the skin and the lungs. METHODS: We have therefore investigated the prevalence of T cells and their subsets in the different chronic allergic eye conditions by means of immunohistochemistry. RESULTS: We found significantly increased numbers of CD4+, CD45RO+, and HLA-DR+ T cells in the conjunctiva of patients with atopic and vernal keratoconjunctivitis and giant papillary conjunctivitis, with a corresponding upregulation of markers present on antigen presenting cells. CONCLUSIONS: These findings suggest that like allergic conditions in the skin and lungs, CD4+ memory T cells are involved in the regulation of the immunopathology of chronic allergic eye responses. Further characterization of these T cells will provide the information necessary for future immunotherapeutic interventions. (J ALLERGY CLIN IMMUNOL 1996;98:686-96.)

Keywords

Allergy
eye
conjunctiva
immunology
T cells
immunohistochemistry

Abbreviations

ABC:
Atopic blepharoconjunctivitis
AKC:
Atopic keratoconjunctivitis
APCs:
Antigen presenting cells
GPC:
Giant papillary conjunctivitis
LC:
Langerhans cell
mAb:
Monoclonal antibody
MLA:
Mucosal lymphocyte antigen
TBS:
Tris-buffered saline
VKC:
Vernal keratoconjunctivitis

Cited by (0)

From aYale University, Section of Immunobiology; b Moorfields Eye Hospital, London; cSouthampton General Hospital; and dInstitute of Ophthalmology, London.

☆☆

Supported by Fight for Sight, Institute of Ophthalmology, London.

Reprint requests: Susan Lightman, PhD, Moorfields Eye Hospital, City Road, London, EC1V 2EL, England.

★★

0091-6749/96 $5.00 + 0 1/1/73119